[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Orchestra Biomed Hldgs Inc (OBIO)

Orchestra Biomed Hldgs Inc (OBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 307,137
  • Shares Outstanding, K 60,105
  • Annual Sales, $ 33,480 K
  • Annual Income, $ -52,700 K
  • EBIT $ -58 M
  • EBITDA $ -57 M
  • 60-Month Beta 0.50
  • Price/Sales 9.44
  • Price/Cash Flow N/A
  • Price/Book 16.30

Options Overview Details

View History
  • Implied Volatility 169.79% (+77.14%)
  • Historical Volatility 62.71%
  • IV Percentile 30%
  • IV Rank 19.42%
  • IV High 874.43% on 03/03/26
  • IV Low 0.00% on 09/05/25
  • Expected Move (DTE 21) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 61
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 1,662
  • Open Int (30-Day) 1,880
  • Expected Range 5.17 to 5.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.41
  • Number of Estimates 4
  • High Estimate $-0.38
  • Low Estimate $-0.45
  • Prior Year $-0.40
  • Growth Rate Est. (year over year) -2.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.78 +36.64%
on 07/29/26
5.78 -10.64%
on 08/19/26
+1.31 (+33.81%)
since 07/28/26
3-Month
3.56 +45.29%
on 07/23/26
5.78 -10.64%
on 08/19/26
+1.18 (+29.77%)
since 05/28/26
52-Week
2.20 +134.77%
on 09/24/25
5.78 -10.64%
on 08/19/26
+2.45 (+90.59%)
since 08/28/25

Most Recent Stories

More News
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

NEW HOPE, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical...

OBIO : 5.21 (+1.86%)
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

NEW HOPE, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies...

OBIO : 5.21 (+1.86%)
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference

NEW HOPE, Pa., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical...

WFC : 86.33 (+1.60%)
OBIO : 5.21 (+1.86%)
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference

NEW HOPE, Pa., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies...

OBIO : 5.21 (+1.86%)
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates

The BACKBEAT global pivotal trial (“BACKBEAT Trial”), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable randomized patients by end of Q3 2026, with primary...

MDT : 91.05 (+1.20%)
OBIO : 5.21 (+1.86%)
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates

The BACKBEAT global pivotal trial (“BACKBEAT Trial”), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable...

MDT : 91.05 (+1.20%)
OBIO : 5.21 (+1.86%)
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes

NEW HOPE, Pa., June 29, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical...

OBIO : 5.21 (+1.86%)
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes

NEW HOPE, Pa., June 29, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies...

OBIO : 5.21 (+1.86%)
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW HOPE, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical...

OBIO : 5.21 (+1.86%)
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW HOPE, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies...

OBIO : 5.21 (+1.86%)

Business Summary

Orchestra BioMed Inc. is a biomedical company accelerating high-impact technologies to patients. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy(TM)for the treatment of hypertension and Virtue(R) Sirolimus AngioInfusion(TM) Balloon for the treatment of atherosclerotic...

See More

Key Turning Points

3rd Resistance Point 5.64
2nd Resistance Point 5.53
1st Resistance Point 5.32
Last Price 5.21
1st Support Level 5.00
2nd Support Level 4.89
3rd Support Level 4.68

See More

52-Week High 5.78
Last Price 5.21
Fibonacci 61.8% 4.41
Fibonacci 50% 3.99
Fibonacci 38.2% 3.57
52-Week Low 2.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.